Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Allarity Therapeutics, Inc. - Common stock (NQ: ALLR ) 0.1680 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Allarity Therapeutics, Inc. - Common stock < Previous 1 2 3 4 5 6 7 8 9 10 Next > Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives Today 6:30 EDT From Allarity Therapeutics, Inc. Via GlobeNewswire Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 17, 2024 Via Benzinga Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance June 27, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer June 25, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered June 24, 2024 Allarity Therapeutics shares are trading lower by 27.6% during Monday's session. The company announced that it received a noncompliance letter from the Nasdaq. Via Benzinga Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher June 24, 2024 Via Benzinga Topics Stocks Exposures US Equities Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 24, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning! Via InvestorPlace Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement May 20, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire ALLR Stock Earnings: Allarity Therapeutics Reported Results for Q1 2024 May 15, 2024 Allarity Therapeutics just reported results for the first quarter of 2024. Via InvestorPlace Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances May 14, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session May 07, 2024 Via Benzinga Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock May 07, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session May 06, 2024 Via Benzinga Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1 May 06, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session May 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 02, 2024 Via Benzinga Why Is Nano-Cap Allarity Therapeutics Stock Trading Up On Thursday? May 02, 2024 Allarity Therapeutics halts Phase 2 trial, citing compelling early results and plans for regulatory advancement. CEO Thomas Jensen affirms strategic shift. ALLR shares surge 38%. Via Benzinga JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock May 02, 2024 Carvana stock is climbing higher on Thursday after shares of CVNA got an increased price target and upgrade from JPMorgan analyst Rajat Gupta. Via InvestorPlace Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts May 02, 2024 Emergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities. Via InvestorPlace Topics Workforce Exposures Layoff Why Is Allarity Therapeutics (ALLR) Stock Up 39% Today? May 02, 2024 Allarity Therapeutics stock is rising higher on Thursday as investors in ALLR celebrate the company ending a clinical trial early. Via InvestorPlace Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results May 02, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 02, 2024 Via Benzinga Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer May 02, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement April 29, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session April 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session April 18, 2024 Via Benzinga Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1) April 17, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session April 15, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 15, 2024 We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning! Via InvestorPlace Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket April 15, 2024 Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.